Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / RYTM - Rhythm Pharmaceuticals Inc. (RYTM) CEO David Meeker on Q1 2022 Results - Earnings Call Transcript

RYTM - Rhythm Pharmaceuticals Inc. (RYTM) CEO David Meeker on Q1 2022 Results - Earnings Call Transcript

Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals, Inc. (RYTM) Q1 2022 Earnings Conference Call May 03, 2022 08:30 AM ET Company Participants David Connolly - Investor Relations and Corporate Communications David Meeker - Chair, President and Chief Executive Officer Jennifer Chien - Executive Vice President, Head of North America Linda Shapiro - Chief Medical Officer Hunter Smith - Chief Financial Officer Yann Mazabraud - Executive Vice President, Head of International Conference Call Participants Derek Archila - Wells Fargo Joseph Stringer - Needham & Company Michael Higgins - Ladenburg Thalmann Jeff hung - Morgan Stanley Corinne Jenkins - Goldman Sachs Presentation Operator Welcome to the Rhythm Pharmaceuticals First Quarter 2022 Earnings Conference Call. My name is Hilda and I'll be your operator today's call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session [Operator Instructions]. I would now turn the call over to, David Connolly, Investor Relations and

For further details see:

Rhythm Pharmaceuticals, Inc. (RYTM) CEO David Meeker on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Rhythm Pharmaceuticals Inc.
Stock Symbol: RYTM
Market: NASDAQ
Website: rhythmtx.com
Menu
RYTM RYTM Quote RYTM Short RYTM News RYTM Articles RYTM Message Board
Get RYTM Alerts

News, Short Squeeze, Breakout and More Instantly...